FASLG and glioblastoma: A recent study provided evidence that CD95 (the receptor of CD95L, Fas Ligand) is overexpressed in glioblastomas compared to normal neural cells and its level of expression was associated to negative prognosis and to epithelial to mesenchymal transition (EMT) and CSC gene signatures [291].